recipharm.com Open in urlscan Pro
139.162.150.75  Public Scan

Form analysis
1 forms found in the DOM

GET /search/node

<form action="/search/node" method="get" id="search-block-form" accept-charset="UTF-8" siq_id="autopick_9063">
  <div class="js-form-item form-item js-form-type-search form-type-search js-form-item-keys form-item-keys form-no-label">
    <label for="edit-keys" class="visually-hidden">Search</label>
    <input title="Enter the terms you wish to search for." data-drupal-selector="edit-keys" type="search" id="edit-keys" name="keys" value="" size="15" maxlength="128" class="form-search" placeholder="Search...">
  </div>
  <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"><input data-drupal-selector="edit-submit" type="submit" id="edit-submit" value="Search" class="button js-form-submit form-submit"
      placeholder="Search...">
  </div>
</form>

Text Content

Skip to main content
 * Development
   * Drug substance
   * Drug product
   * Analytical chemistry
   * Clinical trial material (CTM)
 * Manufacturing
   * Solids
   * Semi-solids
   * Liquids
   * Inhalation
   * Steriles
   * Ophthalmics
 * Solutions
   * Recipharm Analytical Solutions™
   * Recipharm Inhalation Solutions™
   * Recipharm Pathway to Clinic®
   * Serialisation
 * Bespak
 * Learn
 * Press & events
   * Press
   * Events
   * Insights

 * About Recipharm
   * Annual General Meeting 2021
   * Board of Directors
   * Executive committee
   * Recipharm in brief
   * Sustainability
   * Investor relations
 * Careers
   * Working at Recipharm
   * The Recipharm story
   * Meet our employees
   * Current vacancies
 * Contact
   * Contact us
   * Development services contacts
   * Manufacturing services contacts
   * Locations
     * France
       * Fontaine
       * Kaysersberg
       * Monts
       * Pessac
     * Germany
       * Monheim
       * Wasserburg
       * Zwickau
     * India
       * Bengaluru
       * Karnal / Paonta Sahib
     * Israel
       * Yavne
     * Italy
       * Brescia
       * Lainate
       * Masate
       * Paderno Dugnano
       * Pianezza
     * Portugal
       * Odivelas
       * Queluz
     * Spain
       * Parets
       * Leganés
     * Sweden
       * Höganäs
       * Stockholm city (HQ)
       * Karlskoga
       * Solna
       * Strängnäs
       * Uppsala
       * Uppsala Development
     * UK
       * Cramlington
       * Holmes Chapel
       * Queenborough
       * King’s Lynn
     * USA
       * Research Triangle Park

This block is broken or missing. You may be missing content or you might need to
enable the original module.

Search


MAIN SUB MENU

 * About Recipharm
   * Annual General Meeting 2021
   * Board of Directors
   * Executive committee
   * Recipharm in brief
   * Sustainability
   * Investor relations
 * Careers
   * Working at Recipharm
   * The Recipharm story
   * Meet our employees
   * Current vacancies
 * Contact
   * Contact us
   * Development services contacts
   * Manufacturing services contacts
   * Locations
     * France
       * Fontaine
       * Kaysersberg
       * Monts
       * Pessac
     * Germany
       * Monheim
       * Wasserburg
       * Zwickau
     * India
       * Bengaluru
       * Karnal / Paonta Sahib
     * Israel
       * Yavne
     * Italy
       * Brescia
       * Lainate
       * Masate
       * Paderno Dugnano
       * Pianezza
     * Portugal
       * Odivelas
       * Queluz
     * Spain
       * Parets
       * Leganés
     * Sweden
       * Höganäs
       * Stockholm city (HQ)
       * Karlskoga
       * Solna
       * Strängnäs
       * Uppsala
       * Uppsala Development
     * UK
       * Cramlington
       * Holmes Chapel
       * Queenborough
       * King’s Lynn
     * USA
       * Research Triangle Park

MAIN NAVIGATION

 * Development
   * Drug substance
   * Drug product
   * Analytical chemistry
   * Clinical trial material (CTM)
 * Manufacturing
   * Solids
   * Semi-solids
   * Liquids
   * Inhalation
   * Steriles
   * Ophthalmics
 * Solutions
   * Recipharm Analytical Solutions™
   * Recipharm Inhalation Solutions™
   * Recipharm Pathway to Clinic®
   * Serialisation
 * Bespak
 * Learn
 * Press & events
   * Press
   * Events
   * Insights


THE BRIGHTEST MINDS IN THE CDMO INDUSTRY.

From early development through to commercial manufacturing.


Start your journey...


WE PROUDLY INTRODUCE A NEW ADDITION TO THE RECIPHARM FAMILY



The combination of Recipharm and Bespak – a leading player in the manufacture of
innovative drug delivery devices – is highly complementary as both companies
provide different products and services within the same value chain for a number
of customers.





Read more here



DEVELOPMENT



WHETHER YOU’RE A LARGE OR SMALL PHARMACEUTICAL COMPANY, OUR TALENTED TEAM CAN
DEVELOP AND TRANSFORM YOUR PROMISING MOLECULE INTO A PRODUCT. WE’VE SUPPORTED
MANY CLIENTS OVER THE YEARS, AND YOU CAN BE NEXT.



TORKEL GREN - GENERAL MANAGER



“Recipharm takes responsibility for the full phase I programme, from formulation
to clinical trial implementation with patients.”



START YOUR JOURNEY



MANUFACTURING



With production facilities across the world covering a range of product types
and dosage forms, you can count on our manufacturing expertise to reliably
deliver your product on time, every time. Shall we get started?



ANN FLODIN - GENERAL MANAGER



"We are focused on managing complexity for our customers, this means providing a
full service offering to simplify the supply chain."



CONTINUE YOUR JOURNEY



EVENTS

Upcoming eventsPast eventsUpcoming eventsAll eventsFinancial eventsEventsAll
eventsShow all past202120202019201820172021

EVENT


CPHI WORLDWIDE - HYBRID EVENT 2021

We're excited to participate in this year’s online event 25 Oct - 19 Nov. 

2021.10.25 - 2021.11.19

EVENT


DDL 2021

We are pleased to be exhibiting and sponsoring DDL 2021, taking place online,
8-10 December.

2021.12.08 - 2021.12.10

EVENT


WEBINAR: SELECTING THE RIGHT DRUG DELIVERY TECHNOLOGY FOR PRODUCT DEVELOPMENT

Taking place on 8 December at 3pm UK time / 10am ET, our latest webinar will
focus on exploring the challenges when choosing a drug delivery solution and the
importance of keeping the patients’ nee

2021.12.08
End of page
Join


PRESS

First customer boards Recipharm’s soft mist inhaler technology platform
2021.09.24
Recipharm launches new laboratory to expand analytical services offering
2021.08.24
Notice to attend the annual general meeting of Recipharm AB (publ)
2021.04.09
Read


LEARN

WEBINAR


HOW TO DEVELOP A CANNABINOID INTO A DRUG

WEBINAR


CHALLENGES OF CONTROL DRUG PRODUCT DEVELOPMENT

FACT SHEET


PACKAGING SERVICES

View all
CONTACT US

YOUR CDMO PARTNER

Developing pharmaceuticals can be a tricky business, so let us help.

Contact us




CONTACT US TODAY.

Let our experts offer you a better solution.

Recipharm AB (publ)
Box 603
SE-101 32 Stockholm
Sweden

+46 8 602 52 00 info@recipharm.com
 * Linkedin
 * YouTube

FOOTER MENU

 * Privacy policy
 * Cookies
 * Website terms

© 2021 Recipharm AB (publ). All rights reserved Stormfors Digitalbyrå

We use cookies to ensure that we give you the best experience on our website.

More info
OK, I agree No, thanks
We're offline

Leave a message